Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione

Autor: Ferretti, S, Bertozzi, N, Naldoni, Carlo, Sassoli de' Bianchi, P, De Palma, R, Frassoldati, A, Santini, D, Taffurelli, M, Macellari, G, Bella, M, Pancaldi, Mg, Musolino, A, Pessinaf, Petraglia, F, Castagnetti, F, Foroni, M, Gardini, G, Iotti, C, Vacondio, R, Versari, A, Galli, V, Pini, M, Lazzaretti, Mg, De Santis, G, Pignatti, M, Tazzioli, G, Frezza, Gp, Brandes, A, Salimbeni, S, Saguatti, G, Fiorentino, M, Rossi, Nc, Turchetti, D, Zamagni, C, Feggi, L, Querzoli, P, Succi, S, Bagli, E, Bucchi, Lauro, Danesi, R, Della Chiara, S, Falcini, F, Curcio, A, Maltoni, M, Gianni, L, Polico, R, Raulli, Gd, Sanna, P, Serra, L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3709::a61f37a2993cfb503b8cac78594db27a
http://hdl.handle.net/11392/2396604

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Brachytherapy boost after chemoradiation in anal cancer: a systematic review

Autor: R. Frakulli, Giovanni Frezza, Luca Tagliaferri, Gabriella Macchia, Alessandra Arcelli, Alessio G. Morganti, Andrea Galuppi, Martina Ferioli, Milly Buwenge, Lorenzo Fuccio, E. Farina, Silvia Cammelli

Publikováno v: Journal of Contemporary Brachytherapy

Radio-chemotherapy (RCT) is the primary treatment of anal cancer (AC). However, the role and the optimal total dose of a radiation boost is still unclear. No randomized controlled trials nor systematic reviews have been performed to analyze the effic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eb38b49eba2be7dac04f48cbd7c693f
http://europepmc.org/articles/PMC6052386

High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinoma

Autor: Carlo Fabbri, Maria Pia Foschini, Fabrizio Salvi, Giovanni Frezza, Rossella Miglio, Antonio Piemontese, O. Martelli, Andrea Ambrosini-Spaltro, Luciano Liguori

Publikováno v: Applied immunohistochemistrymolecular morphology : AIMM. 16(3)

The purpose of this study is to establish if mucoid differentiation is associated with responsiveness to preoperative radiochemotherapy (RCT) in rectal adenocarcinomas. Thirty-two patients with rectal adenocarcinomas were preoperatively treated with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3fc0fb3f47448d4759aa04e2e12bfb1
https://pubmed.ncbi.nlm.nih.gov/18301248

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial.

Autor: Ricardi U; Department of Oncology, University of Torino, Torino, Italy., Levis M; Department of Oncology, University of Torino, Torino, Italy., Evangelista A; Clinical Epidemiology, Città della Salute e della Scienza and Centro di Prevenzione Oncologica (CPO) Piemonte, Torino, Italy., Gioia DM; Fondazione Italiana Linfomi Onlus, Alessandria, Italy., Sacchetti GM; Nuclear Medicine, 'Maggiore della Carità' Hospital, Novara, Italy., Gotti M; Department of Hematology, Fondazione, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy., Re A; Department of Hematology, Spedali Civili, Brescia, Italy., Buglione M; Department of Radiation Oncology, University and Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili, Brescia, Italy., Pavone V; Department of Hematology and Bone Marrow Transplant, Hospital Card. G. Panico, Tricase, Italy., Nardella A; Department of Radiation Oncology, Città di Lecce Hospital, Lecce, Italy., Nassi L; Hematology, Department of Translational Medicine, Azienda Ospedaliero Universitaria (AOU) 'Maggiore della Carità' and University of Eastern Piedmont, Novara, Italy., Zanni M; Division of Hematology., Franzone P; Radiation Oncology Department, Servizio Sanitario (SS) Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy., Frezza GP; Radiation Oncology Unit, Bellaria Hospital, Bologna, Italy., Pulsoni A; Haematology Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Grapulin L; Department of Radiotherapy, Policlinico Umberto I Sapienza University of Rome, Rome, Italy., Santoro A; Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Italy., Rigacci L; Department of Hematology., Simontacchi G; Radiation Oncology Unit, AOU Careggi, Florence, Italy., Tani M; Hematology Unit, S Maria delle Croci Hospital, Ravenna, Italy., Zaja F; Department of Haematology, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Udine, Italy., Abruzzese E; Hematology Unit, Sant'Eugenio Hospital, Azienda Sanitaria Locale (ASL) Roma 2, Tor Vergata University, Rome, Italy., Botto B; Hematology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Zilioli VR; Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Rota-Scalabrini D; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute Fondazione del Piemonte per l'Oncologia (FPO), IRCCS, Candiolo, Italy., Freilone R; Hematology Unit, Stabilimento Ospedaliero Ivrea, Torino, Italy., Ciccone G; Clinical Epidemiology, Città della Salute e della Scienza and Centro di Prevenzione Oncologica (CPO) Piemonte, Torino, Italy., Filippi AR; Radiation Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy., Zinzani PL; IRCCS AOU di Bologna; and.; Istituto di Ematologia 'Seràgnoli,' Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università degli Studi, Bologna, Italy.

Publikováno v: Blood advances [Blood Adv] 2021 Nov 09; Vol. 5 (21), pp. 4504-4514.